Particularly, the negative association between the genes CDH2, CDH3, CDH11, CDH13, CDH18 and NAT1 N-acetylation activity supports observations of high NAT1 expression in breast cancer and increased metastasis. This evidence concerns the gene NAT1 and breast carcinoma.